• Work with us
  • External Contractors
Fondazione Toscana Life Sciences
  • IT
  • EN
Toscana Life Sciences
  • THE FOUNDATION
    • Organization
    • History
    • Membership
    • The Legislative Decree No. 231/2001
    • Results
  • Activity
  • Cluster
  • ITS VITA
  • BIOINCUBATOR
    • Join the Bioincubator
    • Incubated companies
    • Research groups
    • Affiliated companies
  • Services
    • Business development services
    • Research services
    • Incubation services
    • Protection of intellectual property
  • Projects
    • Monoclonal Antibody Discovery (MAD) LAB
    • ERC Advanced Grant VACCIBIOME
    • TUMOUR IMMUNOLOGY UNIT
    • Mass Spectrometry Unit
    • BOTANICALS LAB
    • Data Science for Health (DaScH) Lab
    • Regions4PerMed
    • IDF SHARID
    • BORNTOGEtTHERe
    • SINO-EU‐PERMED
    • Orphan diseases
  • Disseminating
    • TLS Open Doors
    • Scientists for a day
    • Science + Economy = Business
    • Researcher’s Night
    • European Biotech Week
  • Stories
Enter any keyword and press enter

Monoclonal Antibody Discovery (MAD) LAB

  • Projects
    • Monoclonal Antibody Discovery (MAD) LAB
    • ERC Advanced Grant VACCIBIOME
    • TUMOUR IMMUNOLOGY UNIT
    • Mass Spectrometry Unit
    • BOTANICALS LAB
    • Data Science for Health (DaScH) Lab
    • Regions4PerMed
    • MammoScreen
    • IDF SHARID
    • BORNTOGEtTHERe
    • SINO-EU‐PERMED

Monoclonal Antibody Discovery (MAD) LAB

General Description
The MAD Lab research team at TLS Foundation started activities in 2018 thanks to a 2.5 million euros  ERC Advanced Grant focused on anti-microbial resistance and has grown quickly thanks to various funding sources received for tackling different health challenges (Shigella, Klebsiella pneumoniae and, more recently, coronavirus SARS-CoV-2). The Lab has consolidated skills in the identification and production of monoclonal antibodies that can be tested in vitro against bacteria and viruses.

Research Activities
The MAD Lab is focused on different research projects:

  1. ERC vAMRes (Vaccines as a remedy against Anti-Microbial Resistance) Project - "Isolation and screening of human monoclonal antibodies against AMR for therapy and for discovery of novel vaccine antigens" aims, through isolation of natural antibodies and identification of the recognised antigens, at developing vaccines able to defeat Neisseria gonorrhoeae (Gonococcus), Streptococcus pneumoniae (Pneumococcus) and Escherichia coli pathogenic strains, thanks to the application of advanced technologies to Reverse Vaccinology developed by Dr. Rino Rappuoli (Principal Investigator of the vAMRes Project) at the end of '90s and now proposed again with a 2.0 approach.
    ERC EUROPEAN GRANT - Duration: 5 years; Starting date: November 2018; Amount: 2.5 Million Euros.
  2. ShiMabs Project - "Human monoclonal antibodies against Shigella (ShiMabs), for therapy and vaccine acceleration" aims at isolating therapeutic monoclonal antibodies against different strains of Shigella, a bacterium responsible for bowel infections, especially in children in the poorest areas of the world.
    WELLCOME TRUST GRANT - Duration: 3 years; Starting date: March 2021; Amount: more than 4 million Euros. 
  3. MabCo19 Project, started in collaboration with INMI Spallanzani, is focused on the discovery and development of human monoclonal antibodies against coronavirus SARS-CoV-2, from blood of recovering/recovered patients, with the aim of using them for prophylactic/therapeutic purposes and as molecular baits for the discovery of vaccine antigens. The experimental approach followed is called Reverse Vaccinology 2.0, which represents the evolution of the first Reverse Vaccinology strategy optimized by Dr. Rino Rappuoli.
    FUNDS: started in March 2020, within the C.Re.Me.P. (Regional Centre for Precision Medicine) Project funded by the Tuscany Region and funds from Achilles Vaccines under the EU Malaria Fund
  4. New Delhi metallo-beta-lactamase-producing (NDM) Klebsiella pneumoniae.The project deals with the isolation of human monoclonal antibodies from patients who recovered from NDM-producing K. pneumoniae infection and, by using an innovative high-throughput imaging platform and deep learning algorithms for image analysis, characterize thousands of mAbs to find the most potent ones. The overarching goal of this project is to identify broadly protective mAbs against highly virulent K. pneumoniae strains, thus providing a therapeutic solution to NDM K. pneumoniae infections.
    C.Re.Me.P. Funds (Tuscany Region) - Duration: 2 years; Starting date: December 2019.
  5. Wellcome Leap - RNA Readiness + Response (R3) Program: Work on the “Development of extremely potent human mRNA-encoded monoclonal antibodies against viral and bacterial pathogens" is supported by Wellcome Leap as part of the R3 Program. 

Contacts:

MAD Lab Coordinator and vAMRes Principal Investigator: Rino Rappuoli

Research Group:
Claudia Sala
c.sala@toscanalifesciences.org

Emanuele Andreano
e.andreano@toscanalifesciences.org

Anna Kabanova a.kabanova@toscanalifesciences.org

Marco Troisi
m.troisi@toscanalifesciences.org

Concetta De Santi c.desanti@toscanalifesciences.org

Ida Paciello i.paciello@toscanalifesciences.org

Fabiola Vacca f.vacca@toscanalifesciences.org

Noemi Manganaro n.manganaro@toscanalifesciences.org

Elisa Pantano e.pantano@toscanalifesciences.org

Giampiero Batani g.batani@toscanalifesciences.org

Emanuele Roscioli e.roscioli@toscanalifesciences.org

Pardis Mokhtary p.mokhtary@toscanalifesciences.org

Samuele Stazzoni s.stazzoni@toscanalifesciences.org

Vittoria Zucconi v.zucconi@toscanalifesciences.org

Chiara Mugnaini c.mugnaini@toscanalifesciences.org

Soraya Bosch s.bosch@toscanalifesciences.org

Valentina Abbiento v.abbiento@toscanalifesciences.org

Matteo Ridelfi m.ridelfi@toscanalifesciences.org

Giada Antonelli g.antonelli@toscanalifesciences.org

Piero Pileri
p.pileri@toscanalifesciences.org

Fondazione Toscana Life Sciences
Via Fiorentina, 1
53100 Siena – ITALIA

  • tel +39 0577 231211
  • fax +39 0577 43444
  • info@toscanalifesciences.org

Twitter Feeds

🗣Se hai esperienza nel Project Management e sei alla ricerca di una nuova sfida professionale unisciti al Project M…

@FondazioneTLS About a Day Ago

🗣Studia, cresci, vola a Siena. Torna la terza edizione di STAYHub, un programma ideato dal polo SAIHUB con Fondazio…

@FondazioneTLS 4 Days Ago

🗣Le nostre imprese ⚙️fanno un'impresa eccezionale. Guardando alle aziende e ai gruppi di ricerca del bioincubatore…

@FondazioneTLS 6 Days Ago

Contatti

    Concedo il consenso al trattamento dei dati personali secondo la nostra Privacy Policy per poter essere contattato da Fondazione Toscana Life Sciences.

©2015-2021 - Fondazione Toscana Life Sciences - P.I. 01194710529 - Codice SDI: SUBM70N - Privacy - Cookie Policy